ReviewCancers2022

Post-Translational Modifications in Tumor-Associated Antigens as a Platform for Novel Immuno-Oncology Therapies.

Anurag Kumar Srivastava et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.